DOCSLIB.ORG

Problems of Somatic Mutation and Cancer Steven A

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Problems of Somatic Mutation and Cancer Steven A Problems and paradigms Problems of somatic mutation and cancer Steven A. Frank* and Martin A. Nowak Summary releasing constraints on cellular reproduction (tumor sup- Somatic mutation plays a key role in transforming normal pressor genes). The great importance of mutation in cancer cells into cancerous cells. The analysis of cancer pro- progression justifies special attention to the nature of somatic gression therefore requires the study of how point mutations and chromosomal mutations accumulate in mutation. cellular lineages. The spread of somatic mutations We focus on the rate processes that govern the accumu- depends on the mutation rate, the number of cell divi- lation of somatic mutations. Key rate processes include the sions in the history of a cellular lineage, and the nature origin of somatic mutations, the accumulation of mutations of competition between different cellular lineages. We in cellular lineages, and the spread of mutated cell lines in consider how various aspects of tissue architecture and cellular competition affect the pace of mutation accu- competition with other cellular lineages. Prevention of cancer mulation. We also discuss the rise and fall of somatic largely means control of the rate at which cellular lineages mutation rates during cancer progression. BioEssays accumulate mutations. Through the study of rate processes, 26:291–299, 2004. ß 2004 Wiley Periodicals, Inc. one can begin to understand how different tissue architectures affect cancer progression and how mutation rates translate Introduction into rates of progression. It has often been noted that cancer arises from a Darwinian process of mutation and selection among somatic cells. But there is a unique aspect of cancer as an evolutionary system The primacy of somatic mutation that has not been emphasized. Many cellular genes function in cancer progression primarily to repress the competitive success of their bearers. Somatic mutation is not the only process that influences (4,5) Although natural selection can sometimes favor self-re- progression to cancer. Changes in the immune system, (6,8) (7) straint,(1,2) the unusual aspect of cells comes from the great hormonal status, gene expression, and signalling (9) number of cellular genes that enforce reproductive prudence. between tissues may affect the probability and the timing Such prudence arose as a necessary component of multi- of cancer progression. But somatic mutation is the only pro- cellularity.(1,3) cess that seems to play a key role in the progression of all Because selection at the organismal level favors re- tissues at all ages—it is the process, we believe, that explains strained cellular reproduction, many genes are tuned to keep most of the variation in age of cancer incidence. rates of cellular reproduction far below their potential. Somatic Perhaps the clearest evidence for the primacy of somatic (10–12) point mutations and chromosomal mutations can therefore mutation comes from germline mutations and from more easily increase cellular division or decrease cellular laboratory models with mechanisms to induce somatic (13) death than could mutations improve birth and death rates in mutation in particular tissues. The additional mutations other evolutionary systems. Put another way, a much higher almost invariably shorten the progression to cancer, and often proportion of mutations will be advantageous at the cellular do so in ways that can be easily understood. The conclusion level than at the organismal level. Somatic mutations that from this is clear: mutations have a powerful effect on the enhance cellular competitiveness may act directly by speeding kinetics of progression. Simple calculations suggest that the rate of cellular reproduction (oncogenes) or indirectly by somatic mutation occurs often enough to be a pervasive force.(14,15) Many other factors also influence the details of progression Funding agencies: National Science Foundation grant DEB–0089741 in particular cases. But it is a mistake to assume that the and National Institutes of Health grant AI24424 (SAF) and The existence of such additional factors means that they must be Packard Foundation and Jeffrey Epstein (MAN). as important as mutation for explaining the variation between *Correspondence to: Steven Frank, Department of Ecology & individuals in the quantitative timing of progression. If one is Evolutionary Biology, University of California, Irvine CA 92697, USA. interested in the details of why a particular tumor forms in E-mail: [email protected] DOI 10.1002/bies.20000 a particular place at a particular time, then those details Published online in Wiley InterScience (www.interscience.wiley.com). dominate. We are interested in the most important factors that affect the overall variation in the kinetics of progression in all BioEssays 26:291–299, ß 2004 Wiley Periodicals, Inc. BioEssays 26.3 291 Problems and paradigms tissues. The evidence strongly supports focus on mutation as If the same stem lineages continue to divide with increasing one of the key factors—perhaps the dominant factor in setting age, then epithelial stem lineages may divide many times. rate-limiting steps in progression. At age 60, an individual has lived about 22,000 days. Let us conservatively estimate human intestine renewal as every How does the architecture of renewing 7 days. Thus, people at age 60 have renewed their intestinal epithelial tissues affect the accumulation epithelium over 3,000 times. If we measure the age of cells as of mutations? the number of divisions in their somatic history, then some Epidermal and intestinal tissue are composed of many small stem cells in epithelial compartments may have divided 3,000 compartments, each compartment with no more than a few times by age 60. hundred to a few thousand cells.(16–20) The cells in different If we suppose that the mutation rate per gene per cell compartments divide independently and renew lost surface division is about 10À7, and there are about 105 genes, then the cells, with little mixing of cells between compartments. Tissue mutation rate per cell division in the coding region of the renewal occurs continuously. For example, the human intes- genome is about 10À2. The average stem lineage after 3,000 tine replaces its surface cells every few days. divisions would have experienced about 30 mutational events. Cairns(21) suggested that renewing tissues may reduce There are roughly 107 compartments in the colon and many the risk of cancer by separating into long-lived stem cells and also in the skin. With so many stem lineages, a large number short-lived transit cells. Stem cells divide repeatedly and of those lineages would experience hundreds of mutations by remain at the base of the epithelial compartments. Normally, the later stages of life. each stem cell division gives rise to one stem cell that remains These calculations suggest that some other process likely at the basal layer and one transit cell. The transit cell divides controls the accumulation of mutations. Cairns(21,26) argued a limited number of times, producing cells that move up from that stem cells may have reduced mutation rates compared the basal layer and eventually slough off from the surface. with other somatic cells. Two processes may reduce mutation For example, recent studies of human epidermal tissue rates. First, in each asymmetric stem cell division, the suggest that the skin renews from relatively slowly dividing stem lineage may retain the original DNA templates, with all basal stem cells that give rise to rapidly dividing transit new DNA copies segregating to the transit lineage. If most lineages, each transit lineage undergoing three to five rounds mutations occur in the production of new DNA strands, then of replication before sloughing from the surface.(19) Studies of most mutations would segregate to the transit lineage, and gastrointestinal compartments estimate four to six rounds of the stem lineage would accumulate fewer mutations per cell division by transit lineages.(22) division.(27,28) Second, stem cells may be particularly prone to The stem lineage renews the compartment and survives apoptosis in response to DNA damage, killing themselves over time. Thus, accumulation of somatic mutations occurs rather than risking repair of damage.(22,29) mainly in the stem lineage. Mutations in transit cells or differ- If these processes reduce stem cell mutation rates, then entiated cells may sometimes contribute to tumorigenesis but, carcinogens or other accidents that kill stem cells may have a in this paper, we focus on what we believe to be the dominant large effect on the accumulation of mutations in compart- rate-limiting steps, which probably occur most often in stem ments.(26) In particular, lost stem cells must be replaced by lineages. normal, symmetric cell division with typical mutation rates that Little is known about the history of stem lineages. For may be much higher than stem cell mutation rates. Thus, example, how many actively dividing stem cells renew a mutations may accumulate during periods in which stem cells compartment? This remains controversial. Potten’s group are being regenerated. estimated 4–6 active stem cells in each mouse intestinal compartment;(20) other estimates range from one stem cell to Is there a hierarchy of stem cells more than half of all cells in a compartment. to flush somatic mutations? With regard to the accumulation of mutations, a more The problem with a separation between stem cells and transit important issue concerns the lineage history of the active stem cells comes from the accumulation of mutations in long stem cells. Occasionally, a stem cell may die. The dead cell may be lineages. A hierarchy of stem cells could reduce the accu- replaced by the daughter of an active stem cell,(20) in which mulation of mutations.(30) We discuss two different mechan- case the total number of divisions in the history of stem isms, which we label stochastic flushing and deterministic lineages continues to increase over time.
Load more

Recommended publications
  • Genomic Profiling Reveals High Frequency of DNA Repair Genetic
    www.nature.com/scientificreports OPEN Genomic profling reveals high frequency of DNA repair genetic aberrations in gallbladder cancer Reham Abdel‑Wahab1,9, Timothy A. Yap2, Russell Madison4, Shubham Pant1,2, Matthew Cooke4, Kai Wang4,5,7, Haitao Zhao8, Tanios Bekaii‑Saab6, Elif Karatas1, Lawrence N. Kwong3, Funda Meric‑Bernstam2, Mitesh Borad6 & Milind Javle1,10* DNA repair gene aberrations (GAs) occur in several cancers, may be prognostic and are actionable. We investigated the frequency of DNA repair GAs in gallbladder cancer (GBC), association with tumor mutational burden (TMB), microsatellite instability (MSI), programmed cell death protein 1 (PD‑1), and its ligand (PD‑L1) expression. Comprehensive genomic profling (CGP) of 760 GBC was performed. We investigated GAs in 19 DNA repair genes including direct DNA repair genes (ATM, ATR , BRCA1, BRCA2, FANCA, FANCD2, MLH1, MSH2, MSH6, PALB2, POLD1, POLE, PRKDC, and RAD50) and caretaker genes (BAP1, CDK12, MLL3, TP53, and BLM) and classifed patients into 3 groups based on TMB level: low (< 5.5 mutations/Mb), intermediate (5.5–19.5 mutations/Mb), and high (≥ 19.5 mutations/Mb). We assessed MSI status and PD‑1 & PD‑L1 expression. 658 (86.6%) had at least 1 actionable GA. Direct DNA repair gene GAs were identifed in 109 patients (14.2%), while 476 (62.6%) had GAs in caretaker genes. Both direct and caretaker DNA repair GAs were signifcantly associated with high TMB (P = 0.0005 and 0.0001, respectively). Tumor PD‑L1 expression was positive in 119 (15.6%), with 17 (2.2%) being moderate or high. DNA repair GAs are relatively frequent in GBC and associated with coexisting actionable mutations and a high TMB.
    [Show full text]
  • Mitosis Vs. Meiosis
    Mitosis vs. Meiosis In order for organisms to continue growing and/or replace cells that are dead or beyond repair, cells must replicate, or make identical copies of themselves. In order to do this and maintain the proper number of chromosomes, the cells of eukaryotes must undergo mitosis to divide up their DNA. The dividing of the DNA ensures that both the “old” cell (parent cell) and the “new” cells (daughter cells) have the same genetic makeup and both will be diploid, or containing the same number of chromosomes as the parent cell. For reproduction of an organism to occur, the original parent cell will undergo Meiosis to create 4 new daughter cells with a slightly different genetic makeup in order to ensure genetic diversity when fertilization occurs. The four daughter cells will be haploid, or containing half the number of chromosomes as the parent cell. The difference between the two processes is that mitosis occurs in non-reproductive cells, or somatic cells, and meiosis occurs in the cells that participate in sexual reproduction, or germ cells. The Somatic Cell Cycle (Mitosis) The somatic cell cycle consists of 3 phases: interphase, m phase, and cytokinesis. 1. Interphase: Interphase is considered the non-dividing phase of the cell cycle. It is not a part of the actual process of mitosis, but it readies the cell for mitosis. It is made up of 3 sub-phases: • G1 Phase: In G1, the cell is growing. In most organisms, the majority of the cell’s life span is spent in G1. • S Phase: In each human somatic cell, there are 23 pairs of chromosomes; one chromosome comes from the mother and one comes from the father.
    [Show full text]
  • Exploring the Interplay of Telomerase Reverse Transcriptase and Β-Catenin in Hepatocellular Carcinoma
    cancers Review Exploring the Interplay of Telomerase Reverse Transcriptase and β-Catenin in Hepatocellular Carcinoma Srishti Kotiyal and Kimberley Jane Evason * Department of Oncological Sciences, Department of Pathology, and Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA; [email protected] * Correspondence: [email protected]; Tel.: +1-801-587-4606 Simple Summary: Liver cancer is one of the deadliest human cancers. Two of the most common molecular aberrations in liver cancer are: (1) activating mutations in the gene encoding β-catenin (CTNNB1); and (2) promoter mutations in telomerase reverse transcriptase (TERT). Here, we review recent findings regarding the interplay between TERT and β-catenin in order to better understand their role in liver cancer. Abstract: Hepatocellular carcinoma (HCC) is one of the deadliest human cancers. Activating muta- tions in the telomerase reverse transcriptase (TERT) promoter (TERTp) and CTNNB1 gene encoding β-catenin are widespread in HCC (~50% and ~30%, respectively). TERTp mutations are predicted to increase TERT transcription and telomerase activity. This review focuses on exploring the role of TERT and β-catenin in HCC and the current findings regarding their interplay. TERT can have contradictory effects on tumorigenesis via both its canonical and non-canonical functions. As a critical regulator of proliferation and differentiation in progenitor and stem cells, activated β-catenin drives HCC; however, inhibiting endogenous β-catenin can also have pro-tumor effects. Clinical studies revealed a significant concordance between TERTp and CTNNB1 mutations in HCC. In Citation: Kotiyal, S.; Evason, K.J. stem cells, TERT acts as a co-factor in β-catenin transcriptional complexes driving the expression Exploring the Interplay of Telomerase of WNT/β-catenin target genes, and β-catenin can bind to the TERTp to drive its transcription.
    [Show full text]
  • Telomere and Telomerase in Oncology
    Cell Research (2002); 12(1):1-7 http://www.cell-research.com REVIEW Telomere and telomerase in oncology JIAO MU*, LI XIN WEI International Joint Cancer Institute, Second Military Medical University, Shanghai 200433, China ABSTRACT Shortening of the telomeric DNA at the chromosome ends is presumed to limit the lifespan of human cells and elicit a signal for the onset of cellular senescence. To continually proliferate across the senescent checkpoint, cells must restore and preserve telomere length. This can be achieved by telomerase, which has the reverse transcriptase activity. Telomerase activity is negative in human normal somatic cells but can be detected in most tumor cells. The enzyme is proposed to be an essential factor in cell immortalization and cancer progression. In this review we discuss the structure and function of telomere and telomerase and their roles in cell immortalization and oncogenesis. Simultaneously the experimental studies of telomerase assays for cancer detection and diagnosis are reviewed. Finally, we discuss the potential use of inhibitors of telomerase in anti-cancer therapy. Key words: Telomere, telomerase, cancer, telomerase assay, inhibitor. Telomere and cell replicative senescence base pairs of the end of telomeric DNA with each Telomeres, which are located at the end of round of DNA replication. Hence, the continual chromosome, are crucial to protect chromosome cycles of cell growth and division bring on progress- against degeneration, rearrangment and end to end ing telomere shortening[4]. Now it is clear that te- fusion[1]. Human telomeres are tandemly repeated lomere shortening is responsible for inducing the units of the hexanucleotide TTAGGG. The estimated senescent phenotype that results from repeated cell length of telomeric DNA varies from 2 to 20 kilo division, but the mechanism how a short telomere base pairs, depending on factors such as tissue type induces the senescence is still unknown.
    [Show full text]
  • Intercellular Competition and the Inevitability of Multicellular Aging
    Intercellular competition and the inevitability of multicellular aging Paul Nelsona,1 and Joanna Masela aDepartment of Ecology and Evolutionary Biology, University of Arizona, Tucson, AZ 85721 Edited by Raghavendra Gadagkar, Indian Institute of Science, Bangalore, India, and approved October 6, 2017 (received for review November 14, 2016) Current theories attribute aging to a failure of selection, due to Aging in multicellular organisms occurs at both the cellular either pleiotropic constraints or declining strength of selection and intercellular levels (17). Multicellular organisms, by definition, after the onset of reproduction. These theories implicitly leave require a high degree of intercellular cooperation to maintain open the possibility that if senescence-causing alleles could be homeostasis. Often, cellular traits required for producing a viable identified, or if antagonistic pleiotropy could be broken, the multicellular phenotype come at a steep cost to individual cells effects of aging might be ameliorated or delayed indefinitely. (14, 18, 19). Conversely, many mutant cells that do not invest in These theories are built on models of selection between multicel- holistic organismal fitness have a selective advantage over cells lular organisms, but a full understanding of aging also requires that do. If intercellular competition occurs, such “cheater” or examining the role of somatic selection within an organism. “defector” cells may proliferate and displace “cooperating” cells, Selection between somatic cells (i.e., intercellular competition) with detrimental consequences for the multicellular organism can delay aging by purging nonfunctioning cells. However, the (20, 21). Cancer, a leading cause of death in humans at rates that fitness of a multicellular organism depends not just on how increase with age, is one obvious manifestation of cheater pro- functional its individual cells are but also on how well cells work liferation (22–24).
    [Show full text]
  • Human Inheritable Genetic Modifications
    Human Inheritable Genetic Modifications Assessing Scientific, Ethical, Religious, and Policy Issues Prepared by the American Association for the Advancement of Science Mark S. Frankel Audrey R. Chapman September 2000 http://www.aaas.org/spp/dspp/sfrl/germline/main.htm i This report is the product of a collaboration between the authors and a working group convened to advise the authors, and does not necessarily represent the views of American Association for the Advancement of Science or The Greenwall Foundation, which funded this study. Copyright © 2000 American Association for the Advancement of Science Cover: Designed and created by the Office of Publication Services at the American Association for the Advancement of Science. ii Table of Contents Acknowledgements…………………………………………………v Introduction………………………………………………………….1 Major Findings, Concerns, and Recommendations…………………7 Defining Inheritable Genetic Modific ation……………….………..11 Therapeutic Need…………………………………………………..13 Efficacy of Different Approaches to IGM…………………………15 Safety Issues……………………………………………………….23 Inadvertent Germ Line Modific ation………………………………26 Religious Perspectives……………………………………………..27 Ethical Analysis and Considerations……………………………….32 Ethically Appropriate Applications of IGM: Therapy versus Enhancement.………………………………………………………40 Reproductive Rights………………………………………………..44 Balancing Scientific Freedom and Responsibility…………………45 Oversight…………………………………………………………...46 Conclusion.…………………………………………………………56 Glossary…………………………………………………………….59 Appendix A: AAAS Working Group Members……………………65
    [Show full text]
  • Clonal Hematopoietic Mutations Linked to Platelet Traits and the Risk Of
    REVIEW ARTICLE Clonal hematopoietic mutations linked to Ferrata Storti Foundation platelet traits and the risk of thrombosis or bleeding Alicia Veninga, 1,* Ilaria De Simone, 1,* Johan W.M. Heemskerk, 1 Hugo ten Cate, 1,2,3 and Paola E.J. van der Meijden 1,2 1Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht; 2Thrombosis Expertise Center, Heart and Vascular Haematologica 2020 Center, Maastricht University Medical Center, Maastricht and 3Department of Internal Volume 105(8):2020-2031 Medicine, Maastricht University Medical Center, Maastricht, the Netherlands *AV and IDS contributed equally as co-first authors. ABSTRACT latelets are key elements in thrombosis, particularly in atherosclero - sis-associated arterial thrombosis (atherothrombosis), and hemosta - Psis. Megakaryocytes in the bone marrow, differentiated from hematopoietic stem cells are generally considered as a uniform source of platelets. However, recent insights into the causes of malignancies, includ - ing essential thrombocytosis, indicate that not only inherited but also somatic mutations in hematopoietic cells are linked to quantitative or qualitative platelet abnormalities. In particular cases, these form the basis of thrombo-hemorrhagic complications regularly observed in patient groups. This has led to the concept of clonal hematopoiesis of indetermi - nate potential (CHIP), defined as somatic mutations caused by clonal expansion of mutant hematopoietic cells without evident disease. This concept also provides clues regarding the importance of platelet function Correspondence: in relation to cardiovascular disease. In this summative review, we present an overview of genes associated with clonal hematopoiesis and altered P.E.J. VAN DER MEIJDEN platelet production and/or functionality, like mutations in JAK2 . We con - [email protected] sider how reported CHIP genes can influence the risk of cardiovascular disease, by exploring the consequences for platelet function related to Received: January 31, 2020.
    [Show full text]
  • Germline and Somatic Mosaicism in a Family with Multiple Endocrine
    2 180 H J B H Beijers and others Mosaicism in family with MEN1 180:2 K15–K19 Case Report syndrome Germline and somatic mosaicism in a family with multiple endocrine neoplasia type 1 (MEN1) syndrome Hanneke J B H Beijers1,2, Nike M L Stikkelbroeck2, Arjen R Mensenkamp3, Rolph Pfundt3, Rob B van der Luijt4, Henri J L M Timmers2, Ad R M M Hermus2 and Marlies J E Kempers3 Correspondence 1Department of Internal Medicine, Maasziekenhuis Pantein, Boxmeer, The Netherlands, 2Division of Endocrinology, should be addressed Department of Internal Medicine, 3Department of Human Genetics, Radboud University Nijmegen Medical Center, to M J E Kempers 4 Nijmegen, The Netherlands, and Department of Medical Genetics, University Medical Center Utrecht, Utrecht, Email The Netherlands Marlies.Kempers@ radboudumc.nl Abstract Context: Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disease caused by mutations in the tumor suppressor gene MEN1 and can be diagnosed based on clinical, familial and/or genetic criteria. We present a family in which we found both germline and somatic mosaicism for MEN1. Family description: In our proband, we diagnosed MEN1. The mutation was not detected in her parents (DNA extracted from leucocytes). When her brother was found to harbor the same MEN1 mutation as our proband and, around the same time, their father was diagnosed with a neuroendocrine carcinoma, this tumor was investigated for the MEN1 mutation as well. In the histologic biopsy of this tumor, the same MEN1 mutation was detected as previously found in his children. Re-analysis of his blood using multiplex ligation-dependent probe amplification (MLPA) showed a minimal, but consistently decreased signal for the MEN1-specific MLPA probes.
    [Show full text]
  • Periodic Production of Retinoic Acid by Meiotic and Somatic Cells Coordinates Four Transitions in Mouse Spermatogenesis
    Periodic production of retinoic acid by meiotic and somatic cells coordinates four transitions in mouse spermatogenesis Tsutomu Endoa,1,2, Elizaveta Freinkmana,3, Dirk G. de Rooija, and David C. Pagea,b,c,1 aWhitehead Institute, Cambridge, MA 02142; bDepartment of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139; and cHoward Hughes Medical Institute, Whitehead Institute, Cambridge, MA 02142 Contributed by David C. Page, October 4, 2017 (sent for review June 22, 2017; reviewed by Marvin L. Meistrich and Kyle E. Orwig) Mammalian spermatogenesis is an elaborately organized differenti- to become spermatozoa. Finally, these spermatozoa are released ation process, starting with diploid spermatogonia, which include into the lumen of seminiferous tubules. germ-line stem cells, and ending with haploid spermatozoa. The The four key transitions of spermatogenesis are precisely co- process involves four pivotal transitions occurring in physical prox- ordinated in time and space and occur in close physical and tem- imity: spermatogonial differentiation, meiotic initiation, initiation of poral proximity, cyclically, with an 8.6-d periodicity in mice (9). The spermatid elongation, and release of spermatozoa. We report how mouse testis is composed of structures known as seminiferous tu- the four transitions are coordinated in mice. Two premeiotic transi- bules (Fig. S1A); within tubule cross-sections, one sees stereotypical tions, spermatogonial differentiation and meiotic initiation, were collections or associations of germ cells at various steps of differ- known to be coregulated by an extrinsic signal, retinoic acid (RA). Our entiation (Fig. 1). The precise coordination of these steps is called the “cycle of the seminiferous epithelium” (or “seminiferous cy- chemical manipulations of RA levels in mouse testes now reveal cle”).
    [Show full text]
  • Ploidy of Living Clones of Human Somatic Cells Determined by Mensuration at Metaphase
    PLOIDY OF LIVING CLONES OF HUMAN SOMATIC CELLS DETERMINED BY MENSURATION AT METAPHASE C. A . SPRAGUE, H. HOEHN, and G. M. MARTIN. From the Department of Pathology, University of Washington, Seattle, Washington 98195 INTRODUCTION the 17th gestational week of a male fetus. General culture conditions were as previously described (11) . Tetraploid clones have been useful for studies of Media was a modification of the Dulbecco-Vogt somatic segregation (10), mutation (4), and the formulation (3) with 16% (vol/vol) heat-inactivated regulation of protein synthesis (14, 13, 12) . With fetal calf serum . Cytochalasin B treatments (2 µg/ml the availability of various heterochromatin mark- for 36 h) for induction of tetraploidy (6) were carried ers, such material is also proving valuable for out 6-8 h after dilute plating of 40-60 cells in 4 nil of cytological studies of interphase (5). Finally, clones media in 60-mm plastic Petri dishes . The cultures of cells with various ploidies should serve as very were then fed every third day . Between days 10 and 15, Downloaded from http://rupress.org/jcb/article-pdf/60/3/781/1387098/781.pdf by guest on 03 October 2021 precise and convenient standards for flow micro- consecutive clones were analyzed by a two-step pro- cedure : (a) four to 12 living mitotic cells were photo- fluorometric assays of cell DNA (8, 1) . We report graphed at the stage of distinct equatorial alignment here a rapid and simple technique for the diagnosis of chromosomes using a Nikon inverted microscope of ploidy in clones of somatic cells derived from (model MS) with a 20X DLL objective and phase human skin and amniotic fluid .
    [Show full text]
  • Human Genome Editing
    Human Genome Editing ETHICAL AND POLICY CONSIDERATIONS – POLICY BRIEF – http://bit.ly/2hi1pAR B.M. KNOPPERS, M.T. NGUYEN, F. NOOHI & E. KLEIDERMAN CENTRE OF GENOMICS AND POLICY (CGP) MCGILL UNIVERSITY AND GÉNOME QUÉBEC INNOVATION CENTRE MONTRÉAL, MARS 2018 Génome Québec Established in 2000, Génome Québec is a private, non-profit organization with its headquarters in Montréal. Its mission is to catalyze the development and excellence of genomics research and promote its integration and democratization. Génome Québec is recognized for its assertive leadership in promoting an optimal environment conducive to the advancement of genomics research and the integration of its benefits into priority sectors for Québec. A strong culture of ethics drives its mission, providing assurance that research will be conducted within ethical guidelines acceptable to society at large. To promote a better understanding and support decision making regarding the complex issues raised by human genome editing, Génome Québec asked the Centre of Genomics and Policy to produce a Policy Brief on the subject. This document is the result of analysis and research conducted by the authors of the CGP. The views expressed herein do not necessarily reflect those of Génome Québec. Centre of Genomics and Policy (CGP) An integral part of the McGill University and Génome Québec Innovation Centre, the Centre of Genomics and Policy (CGP) is at the crossroads of the legal, medical and public policy fields. Within a multidisciplinary perspective and in cooperation with national and international partners, the CGP analyzes the ethical, legal and social norms that influence the many aspects involved in health prevention, protection and promotion.
    [Show full text]
  • Dedifferentiation, Transdifferentiation, and Reprogramming: Future Directions in Regenerative Medicine
    82 Dedifferentiation, Transdifferentiation, and Reprogramming: Future Directions in Regenerative Medicine Cristina Eguizabal, PhD1 Nuria Montserrat, PhD1 Anna Veiga, PhD1,2 Juan Carlos Izpisua Belmonte, PhD1,3 1 Center for Regenerative Medicine in Barcelona Address for correspondence and reprint requests Juan Carlos Izpisua 2 Reproductive Medicine Service, Institut Universitari Dexeus, Belmonte, PhD, Gene Expression Laboratory, The Salk Institute for Barcelona, Spain Biological Studies, 10010 North Torrey Pines Road, La Jolla, CA 93027 3 Gene Expression Laboratory, The Salk Institute for Biological Studies, (e-mail: [email protected]). La Jolla, California Semin Reprod Med 2013;31:82–94 Abstract The main goal of regenerative medicine is to replace damaged tissue. To do this it is Keywords necessary to understand in detail the whole regeneration process including differenti- ► regenerative ated cells that can be converted into progenitor cells (dedifferentiation), cells that can medicine switch into another cell type (transdifferentiation), and somatic cells that can be ► stem cells induced to become pluripotent cells (reprogramming). By studying the regenerative ► dedifferentiation processes in both nonmammal and mammal models, natural or artificial processes ► transdifferentiation could underscore the molecular and cellular mechanisms behind these phenomena and ► reprogramming be used to create future regenerative strategies for humans. To understand any regenerative system, it is crucial to find the potency and differentiate and how they can revert to pluri- cellular origins of renewed tissues. Using techniques like potency (reprogramming) or switch lineages (dedifferentia- genetic lineage tracing and single-cell transplantation helps tion and transdifferentiation). to identify the route of regenerative sources. These tools were We synthesize the studies of different model systems to developed first in nonmammal models (flies, amphibians, and highlight recent insights that are integrating the field.
    [Show full text]